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Abstract The presence of Kayser–Fleischer ring in
patients with Wilson’s disease (WD) is well documented
and included in diagnostic algorithms; however, data about
the occurrence of the second postulated ophthalmological
sign of WD, sunflower cataract (SC), are limited and even
conflicting. The aim of our study was to verify the occur-
rence of SC in WD. From January 2010 to May 2015, 81
consecutive, newly diagnosed WD patients underwent
detailed ophthalmological examinations, including slit
lamp examination with special attention to lens trans-
parency, to verify the presence of SC in WD-naive patients.
SC was detected in only one (1.2 %) of the examined WD
patients, did not impact visual acuity; moreover, com-
pletely disappeared following a year of treatment for WD.
SC may be a very rare and reversible ophthalmological
manifestation of WD that is observed seldom and only at
the time of WD diagnosis. We postulate that a finding of
SC in WD patients is an interesting finding that may occur
in the course of WD, but it is not a pathognomonic sign of
WD.
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Introduction
Wilson’s disease (WD; OMIM No. 277900) is a genetic
disorder of copper metabolism that results in copper accu-
mulation in many tissues, mainly the liver, brain, cornea, and
kidney. There is often secondary damage of affected organs
and clinical manifestations related to the damaged organs [1–
5]. The hepatic, neurological, and psychiatric signs and
symptoms of WD are well described and characterized [1–7].
However, aside from the Kayser–Fleischer ring (K-F ring),
which is produced by copper deposition in Descemet’s
membrane and is regarded as a typical sign of WD, oph-
thalmologic signs of WD are rarely mentioned in WD
research papers [1–5, 8–14]. Sunflower cataract (SC) is
considered a second ophthalmic sign of WD and has been
called pathognomonic for WD [8–14]. SC consists of a thin,
centralized opacification that is located directly under the
anterior capsule and encompasses between one-third and
one-half of the anterior lens pole surface area. In all cases, the
central opacification is surrounded by additional, secondary
opacifications arranged in ray-like structures around it. This
pattern resembles a sunflower, with a large central disk
surrounded by petals (Fig. 1).
The K-F ring is an important clinical sign that is
included in WD diagnostic algorithms and measures of
treatment efficacy [1]. SC was initially described as a
pathognomonic sign for WD almost 90 years ago [9], and
this description has been repeated often in WD review
articles [1–5]. However, SC is not included in the diag-
nostic criteria for WD and has been reported rarely, even in
case reports [1, 14]. Potential reasons for the low occur-
rence of SC in WD patients are that it is an infrequent
occurrence or that there is a lack of involvement of oph-
thalmologists who are experienced in SC diagnosis [9–13].
Because the ophthalmological manifestations of WD are
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reversible, the aim of our study was to analyze the occur-
rence of SC in a cohort of untreated, newly diagnosed WD
patients in order to verify the importance and frequency of
this sign in association with WD.
Materials and methods
Patients and methods
We examined 81 consecutive, newly diagnosed WD patients
between January 2010 and May 2015. All patients were
diagnosed with WD according to international criteria [1].
Presymptomatic and neurologically and hepatically predom-
inant forms of the disease were distinguished according to the
presence and intensity of clinical signs and symptoms at the
time of diagnosis, as previously described [3]. The study was
approved by the bioethics committee of the institution, and
written informed consent was obtained from all patients.
The one ophthalmologist conducted all of the examina-
tions. All patients underwent formal ophthalmological
examinations, including best-corrected visual acuity (BCVA),
near vision, and slit lamp examination. The patients’ pupils
were then dilated (1 % tropicamide), and lens examination
was performed. Special attention was paid to lens trans-
parency, and the occurrence of SC and K-F ring was noted.
Statistical analysis
All data were analyzed with Statistica v.10 (Stat Soft Inc.,
Tulsa, OK, USA). Mean, range, percentage, and standard
deviation (SD) were measured for descriptive summary
statistics.
Results
Demographic and clinical data of the WD patients involved
in the study are presented in Table 1. In our analysis of 81
WD patients, according to ophthalmological presentation
of the disease, SC was found in only one WD patient
(1.2 %), who exhibited an exclusive hepatic presentation.
SC was found to have disappeared after 1 year of WD
treatment with d-penicillamine.
The patient’s SC did not impact visual acuity. The
BCVA of the affected WD patient was 0.9 in the right eye,
which was the more affected lens, and 1.0 in the left eye,
with full near vision acuity. SC disappeared from both eyes
after treatment for WD, with both eyes reaching 1.0 BCVA
upon examination. We did not detect any other distur-
bances in lens transparency.
K-F ring was identified in 67.9 % (55/81) of the
examined patients, and its frequency depended upon the
phenotypic presentation of the disease. It was detected in
100 % (34/34) and 57.5 % (19/33) of patients with neu-
rological and hepatic manifestation of the disease, respec-
tively. Only 14.2 % (2/14) of asymptomatic patients had
K-F ring.
Discussion
The ocular symptoms K-F ring and SC have historically
been considered pathognomonic for WD [1]. The occur-
rence of K-F ring in WD is well documented, and it is a key
sign in diagnostic algorithms for the disease [1]. SC, first
described in 1922 by Siemerling and Oloff [9], was also
initially postulated as a sign associated with WD [1].
However, apart from single case reports and two small
ophthalmological studies (53 and 32 nonhomogenous WD
patients), which presented conflicting results regarding SC
occurrence (1.9–17 %), there have been no reports docu-
menting the occurrence and significance of SC in WD [11–
14].
To our knowledge, this was the first ophthalmological
study in which the aim was to verify the occurrence and
significance of SC in a relatively large cohort of newly
diagnosed, untreated WD patients. We found a 1.2 %
occurrence of SC in untreated WD patients. According to
this finding, SC is a very rare and perhaps even incidental
ophthalmological finding in WD that, as with other copper
accumulation WD symptoms (e.g., K-F ring and WD-as-
sociated brain magnetic resonance imaging changes), may
Fig. 1 Sunflower cataract (SC) seen with slit lamp at time of WD
diagnosis
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disappear during the course of disease treatment (as in our
case) [1–3, 15, 16].
The presence of SC appeared to have a limited effect on
patient visual acuity. This should be emphasized, as clas-
sical cataracts usually have a marked effect on visual
acuity. Cataract is caused by irreversible protein changes in
the lens, leading to diminishing lens transparency and,
consequently, reduced visual acuity. SC is not a ‘‘true’’
cataract, as it is caused by reversible copper deposition
under the anterior capsule of the lens [10–14, 18]. Fur-
thermore, we found no cases of ‘‘true’’ cataract in our
group; this is probably due to the young age of the WD
patients in this population.
In any discussion of the significance and occurrence of
SC as a medical symptom, it is worth mentioning that
similar ocular symptoms may occur in eyes with foreign
bodies, including copper [19–21]. High copper ion levels in
intraocular foreign bodies (IOFBs) may lead to chalcosis
bulbi. This phenomenon is dependent on the copper ion
concentration in IOFBs. If the copper concentrations level
is over 85 % it can produce inflammation with hypopyon,
sterile endophthalmitis, and rapidly progress to phthisis.
Chronic mild chalcosis (caused by IOFBs with copper
concentration lower than 85 %) can produce K-F ring, SC
and anterior chamber crystals [19–21]. However, unlike
K-F ring, SC has not yet been reported in other medical
conditions in which increased serum copper levels occur
(e.g., neoplastic disorders and estrogen intake) [17, 22–24].
In patients with WD, the occurrence of SC has always been
reported in patients with K-F ring, with both acting as
ocular WD signs; to our knowledge, SC has never been
reported as an isolated symptom in WD [17–24].
Our study also demonstrated the occurrence of K-F ring
in WD patients; this is concordant with the results of pre-
vious studies. The frequency of K-F ring in WD patients is
well documented and particularly affects patients with
neurological presentation of the disease. However, our
results also highlight the limitations of ophthalmological
examinations when diagnosing WD in patients without
neurological symptoms (especially presymptomatic
patients) [1, 2].
A limitation of our study is that the group of analyzed
patients could have been larger; however, this is the largest
study group thus far of newly diagnosed WD patients who
were examined for the presence of SC. Furthermore, our
cohort was a homogenous group of patients who had not
been treated previously.
Conclusions
SC is a very rare symptom of WD that may disappear
following treatment. This may be of interest to specialists
involved in the diagnosis and treatment of WD, as it is a
rare WD symptom that may sometimes aid in definitive
diagnosis [25]. The presence of SC, in combination with
K-F ring could point physicians toward a WD diagnosis.
However, due to the extreme rarity of its occurrence, as
well as its occurrence in other medical conditions, such as
the presence of foreign intraocular bodies containing cop-
per, it should not be considered a pathognomonic ocular
sign of WD.
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Age at onset of WD symptoms (years) 28.6 ± 11.4
Age at WD diagnosis (years) 32.3 ± 11.8




Baseline copper metabolism parameters
Ceruloplasmin, mg/dl (normal range 25–45 mg/dl) 13.79 ± 6.1
Serum copper level, lg/dl (normal range
70–140 lg/dl)
60.23 ± 31.2
Urine copper excretion, lg/24 h (normal range
0–50 lg/24 h)
328.6 ± 854.9
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